The Latest Breaking News on Pharma

AMD revealed its next-gen RDNA 4 graphics cards, and the info available so far is enough for me to make a final decision on my next PC upgrade.

London-based FTSE 100 firm reviewing its policies, saying it is obliged to comply because US is its No 1 market

Mr Schumacher was named CEO in 2023 following the retirement of Alan Jope but has now stepped down in a surprise move

The pharma industry is delivering game-changing therapies with favorable regulatory support. Amid this backdrop, investors might consider adding three well-positioned biotech stocks such as Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN), and Gilead Sciences (GILD), for potential gains. Learn more….

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and transformative partnerships. To capitalize on this trend, consider adding Amgen (AMGN), BioNTech (BNTX), and Gilead Sciences (GILD), which could boost your portfolio.

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids

When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions – or blame – over responsibility

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 guidance. Here's what you need to know.

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision.